Skip to main content
HOPA Abstracts
Perceptions of PGY2 Oncology Programs on Financial Toxicity Education and Preparedness
Abstract #CR08
Read More
HOPA Abstracts, Chemotherapy
Pharmacist-Led Oral Chemotherapy Monitoring Pilot Study and Assessment of Patient-Reported Outcomes and Adherence
Abstract #CR09
Read More
HOPA Abstracts, Immunotherapy
The Impact of a Comprehensive Immunotherapy Continuing Education Curriculum on Pharmacists’ Knowledge, Competence, and Confidence
Abstract #CR10
Read More
HOPA Abstracts, Leukemia, Venetoclax
Effect of Concomitant Azole Antifungals on Duration of Myelosuppression in Newly Diagnosed Patients with AML Receiving Venetoclax in Combination with Cladribine and Low-Dose Cytarabine
Abstract #LB01
Read More
HOPA Abstracts
The Safety of FOLFIRINOX Regimen: Oxaliplatin and Irinotecan Sequence of Administration
Abstract #LB02
Read More
HOPA Abstracts
Evaluation of the Reliability of 5-FU Elastomeric Pump in an Ambulatory Infusion Center
Abstract #LB03
Read More
HOPA Abstracts, Breast Cancer
Time to Treatment Initiation and Outcomes for Patients with Nonmetastatic Breast Cancer Before and During the COVID-19 Pandemic at Community Cancer Centers
Abstract #LB04
Read More
Meeting Highlights
ASH Highlights
Mosunetuzumab, a Bispecific Antibody, Induces Deep Remissions in Relapsed or Refractory Follicular Lymphoma
Read More
FDA Updates
Enobosarm Granted Fast-Track FDA Review for AR- and ER-Positive, HER2-Negative Metastatic Breast Cancer
Read More
FDA Updates
FDA Grants Gedatolisib, a Dual PI3K and mTOR Inhibitor, Fast-Track Review for ER-Positive, HER2-Negative Breast Cancer
Read More
Page 57 of 198
Results 561 - 570 of 1973